(OCSL) Oaktree Specialty Lending - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 1.042m USD | Total Return: -7.2% in 12m
First Lien Debt, Second Lien Debt, Mezzanine Loans, Preferred Equity
Total Rating 30
Safety 25
Buy Signal -1.04
Asset Management
Industry Rotation: -4.1
Industry Rotation: -4.1
Market Cap:
1.04B
Avg Turnover: 8.87M
Avg Turnover: 8.87M
Risk 3d forecast
Volatility20.8%
VaR 5th Pctl3.90%
VaR vs Median13.6%
Reward TTM
Sharpe Ratio-0.44
Rel. Str. IBD28.5
Rel. Str. Peer Group48.2
Character TTM
Beta0.703
Beta Downside0.858
Hurst Exponent0.540
Drawdowns 3y
Max DD34.16%
CAGR/Max DD-0.08
CAGR/Mean DD-0.19
EPS (Earnings per Share)
EPS CAGR: -15.53%
EPS Trend: -94.5%
EPS Trend: -94.5%
Last SUE: 0.41
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: -3.10%
Rev. Trend: -12.4%
Rev. Trend: -12.4%
Last SUE: -0.28
Qual. Beats: 0
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Description: OCSL Oaktree Specialty Lending
Oaktree Specialty Lending Corporation (OCSL) is a business development company (BDC) that provides customized financing solutions to small and mid-sized companies. The firm focuses on North American middle-market entities, primarily utilizing first and second lien debt, bridge financing, and mezzanine loans to support acquisitions, management buyouts, and corporate expansions.
The fund targets companies with enterprise values ranging from $20 million to $150 million across diverse sectors including healthcare, software, and manufacturing. As a BDC, OCSL is required by law to distribute at least 90% of its taxable income to shareholders, a structure designed to provide capital to private businesses that may lack access to traditional public markets.
OCSL typically acts as a lead investor, underwriting transactions up to $100 million with individual hold sizes reaching $75 million. This business model relies on floating-rate debt instruments, which often allow the lender to benefit from rising interest rate environments. Investors can further examine these portfolio dynamics and yield metrics on ValueRay.
- Interest rate fluctuations impact net investment income from floating rate loan portfolio
- Credit quality of middle market borrowers determines non-accrual rates and valuations
- Synergies from Oaktree Capital Management platform enhance deal flow and underwriting
- Portfolio concentration in first lien debt mitigates potential principal loss during downturns
- Dividend coverage ratios and distribution levels influence investor demand and stock premium
Piotroski VR‑10 (Strict)
3.0
| Net Income: 49.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -7.41 > 1.0 |
| NWC/Revenue: -113.5% < 20% (prev 123.6%; Δ -237.1% < -1%) |
| CFO/TA 0.00 > 3% & CFO 12.5m > Net Income 49.6m |
| Net Debt (1.43b) to EBITDA (128.9m): 11.10 < 3 |
| Current Ratio: 0.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (88.1m) vs 12m ago 2.53% < -2% |
| Gross Margin: 78.50% > 18% (prev -0.01%; Δ 7.85k% > 0.5%) |
| Asset Turnover: 9.54% > 50% (prev 3.96%; Δ 5.58% > 0%) |
| Interest Coverage Ratio: 1.18 > 6 (EBITDA TTM 128.9m / Interest Expense TTM 109.4m) |
Altman Z''
-2.21
| A: -0.11 (Total Current Assets 110.5m - Total Current Liabilities 434.0m) / Total Assets 2.89b |
| B: -0.33 (Retained Earnings -968.9m / Total Assets 2.89b) |
| C: 0.04 (EBIT TTM 128.9m / Avg Total Assets 2.99b) |
| D: -0.64 (Book Value of Equity -968.0m / Total Liabilities 1.51b) |
| Altman-Z'' Score: -2.21 = D |
What is the price of OCSL shares?
As of May 21, 2026, the stock is trading at USD 11.80 with a total of 679,964 shares traded.
Over the past week, the price has changed by -1.67%, over one month by -9.37%, over three months by +5.89% and over the past year by -7.21%.
Over the past week, the price has changed by -1.67%, over one month by -9.37%, over three months by +5.89% and over the past year by -7.21%.
Is OCSL a buy, sell or hold?
Oaktree Specialty Lending has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold OCSL.
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OCSL price?
| Analysts Target Price | 12.4 | 5.3% |
Oaktree Specialty Lending (OCSL) - Fundamental Data Overview
as of 20 May 2026
P/E Trailing = 20.0508 P/E Forward = 22.8311
P/S = 3.4138
P/B = 0.7712
P/EG = 0.9343
Revenue TTM = 284.9m USD
EBIT TTM = 128.9m USD
EBITDA TTM = 128.9m USD
Long Term Debt = 1.05b USD (estimated: total debt 1.48b - short term 434.0m)
Short Term Debt = 434.0m USD (from shortTermDebt, last quarter)
Debt = 1.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.43b USD (from netDebt column, last quarter)
Enterprise Value = 2.47b USD (1.04b + Debt 1.48b - CCE 51.3m)
Interest Coverage Ratio = 1.18 (Ebit TTM 128.9m / Interest Expense TTM 109.4m)
EV/FCF = 197.5x (Enterprise Value 2.47b / FCF TTM 12.5m)
FCF Yield = 0.51% (FCF TTM 12.5m / Enterprise Value 2.47b)
FCF Margin = 4.39% (FCF TTM 12.5m / Revenue TTM 284.9m)
Net Margin = 17.43% (Net Income TTM 49.6m / Revenue TTM 284.9m)
Gross Margin = 78.50% ((Revenue TTM 284.9m - Cost of Revenue TTM 61.2m) / Revenue TTM)
Gross Margin QoQ = 86.31% (prev 87.83%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.47b / Total Assets 2.89b)
Interest Expense / Debt = 1.73% (Interest Expense 25.6m / Debt 1.48b)
Taxrate = 3.57% (1.25m / 35.2m)
NOPAT = 124.3m (EBIT 128.9m * (1 - 3.57%))
Current Ratio = 0.25 (Total Current Assets 110.5m / Total Current Liabilities 434.0m)
Debt / Equity = 1.07 (Debt 1.48b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 11.10 (Net Debt 1.43b / EBITDA 128.9m)
Debt / FCF = 114.2 (Net Debt 1.43b / FCF TTM 12.5m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.66% (Net Income 49.6m / Total Assets 2.89b)
RoE = 3.45% (Net Income TTM 49.6m / Total Stockholder Equity 1.44b)
RoCE = 5.18% (EBIT 128.9m / Capital Employed (Equity 1.44b + L.T.Debt 1.05b))
RoIC = 4.22% (NOPAT 124.3m / Invested Capital 2.95b)
WACC = 4.47% (E(1.04b)/V(2.52b) * Re(8.46%) + D(1.48b)/V(2.52b) * Rd(1.73%) * (1-Tc(0.04)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.89 | Cagr: 5.65%
[DCF] Terminal Value 82.52% ; FCFF base≈104.1m ; Y1≈76.1m ; Y5≈43.2m
[DCF] Fair Price = N/A (negative equity: EV 1.34b - Net Debt 1.43b = -88.2m; debt exceeds intrinsic value)
EPS Correlation: -94.48 | EPS CAGR: -15.53% | SUE: 0.41 | # QB: 0
Revenue Correlation: -12.43 | Revenue CAGR: -3.10% | SUE: -0.28 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.36 | Chg30d=-2.54% | Revisions=-25% | Analysts=6
EPS current Year (2026-09-30): EPS=1.50 | Chg30d=-0.81% | Revisions=-25% | GrowthEPS=-14.9% | GrowthRev=-10.2%
EPS next Year (2027-09-30): EPS=1.41 | Chg30d=-4.06% | Revisions=-56% | GrowthEPS=-5.7% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: -56%